BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36173579)

  • 1. Generation of Epigenetic Disease Model Mice by Targeted Demethylation of the Epigenome.
    Horii T; Morita S; Hatada I
    Methods Mol Biol; 2023; 2577():255-268. PubMed ID: 36173579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful generation of epigenetic disease model mice by targeted demethylation of the epigenome.
    Horii T; Morita S; Hino S; Kimura M; Hino Y; Kogo H; Nakao M; Hatada I
    Genome Biol; 2020 Apr; 21(1):77. PubMed ID: 32234052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editing of DNA Methylation Using dCas9-Peptide Repeat and scFv-TET1 Catalytic Domain Fusions.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2018; 1767():419-428. PubMed ID: 29524149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient generation of epigenetic disease model mice by epigenome editing using the piggyBac transposon system.
    Horii T; Morita S; Kimura M; Hatada I
    Epigenetics Chromatin; 2022 Dec; 15(1):40. PubMed ID: 36522780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of Gene Expression Using dCas9-SunTag Platforms.
    Morita S; Horii T; Hatada I
    Methods Mol Biol; 2023; 2577():189-195. PubMed ID: 36173574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted DNA demethylation of the Fgf21 promoter by CRISPR/dCas9-mediated epigenome editing.
    Hanzawa N; Hashimoto K; Yuan X; Kawahori K; Tsujimoto K; Hamaguchi M; Tanaka T; Nagaoka Y; Nishina H; Morita S; Hatada I; Yamada T; Ogawa Y
    Sci Rep; 2020 Mar; 10(1):5181. PubMed ID: 32198422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele-Specific Epigenome Editing.
    Bashtrykov P; Jeltsch A
    Methods Mol Biol; 2018; 1767():137-146. PubMed ID: 29524132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review.
    Syding LA; Nickl P; Kasparek P; Sedlacek R
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Targeting of TET Activity for Targeted Demethylation Using CRISPR/Cas9.
    Nguyen TV; Lister R
    Methods Mol Biol; 2021; 2272():181-194. PubMed ID: 34009614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on CRISPR/Cas-based epigenetic regulation in plants.
    Jogam P; Sandhya D; Alok A; Peddaboina V; Allini VR; Zhang B
    Int J Biol Macromol; 2022 Oct; 219():1261-1271. PubMed ID: 36057300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editing the Epigenome to Tackle Brain Disorders.
    Liu XS; Jaenisch R
    Trends Neurosci; 2019 Dec; 42(12):861-870. PubMed ID: 31706628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR/Cas mediated epigenome editing for cancer therapy.
    Ansari I; Chaturvedi A; Chitkara D; Singh S
    Semin Cancer Biol; 2022 Aug; 83():570-583. PubMed ID: 33421620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances of epigenetic editing.
    Gjaltema RAF; Rots MG
    Curr Opin Chem Biol; 2020 Aug; 57():75-81. PubMed ID: 32619853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of heritable gene silencing for KRAB-dCas9 + DNMT3 and Ezh2-dCas9 + DNMT3 hit-and-run epigenome editing.
    O'Geen H; Tomkova M; Combs JA; Tilley EK; Segal DJ
    Nucleic Acids Res; 2022 Apr; 50(6):3239-3253. PubMed ID: 35234927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing targeted DNA methylation and demethylation using dCas9.
    Pflueger C; Swain T; Lister R
    Essays Biochem; 2019 Dec; 63(6):813-825. PubMed ID: 31724704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transgenerationally Transmitted DNA Demethylation of a Spontaneous Epialleles Using CRISPR/dCas9-TET1cd Targeted Epigenetic Editing in Arabidopsis.
    Wang M; He L; Chen B; Wang Y; Wang L; Zhou W; Zhang T; Cao L; Zhang P; Xie L; Zhang Q
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo epigenome editing and transcriptional modulation using CRISPR technology.
    Lau CH; Suh Y
    Transgenic Res; 2018 Dec; 27(6):489-509. PubMed ID: 30284145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stabilization of Foxp3 expression by CRISPR-dCas9-based epigenome editing in mouse primary T cells.
    Okada M; Kanamori M; Someya K; Nakatsukasa H; Yoshimura A
    Epigenetics Chromatin; 2017; 10():24. PubMed ID: 28503202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Locus-Specific and Stable DNA Demethylation at the
    Albrecht C; Rajaram N; Broche J; Bashtrykov P; Jeltsch A
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice for in vivo epigenome editing with CRISPR-based systems.
    Gemberling MP; Siklenka K; Rodriguez E; Tonn-Eisinger KR; Barrera A; Liu F; Kantor A; Li L; Cigliola V; Hazlett MF; Williams CA; Bartelt LC; Madigan VJ; Bodle JC; Daniels H; Rouse DC; Hilton IB; Asokan A; Ciofani M; Poss KD; Reddy TE; West AE; Gersbach CA
    Nat Methods; 2021 Aug; 18(8):965-974. PubMed ID: 34341582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.